Announcing a brand new article publication for BIO Integration journal. In this opinion article the authors Fengyi Zeng, Xiaowen Liang and Zhiyi Chen from The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China contemplate new roles for clinicians within the age of synthetic intelligence (AI).
With the fast developments of digital image processing, sample recognition, and clever algorithms, synthetic intelligence (AI) purposes are actually broadly utilized in medication. Applications of synthetic intelligence in medication (AIM) embody prognosis era, remedy choice, healthcare administration and illness stratification. AIM focuses on helping clinicians in illness detection, quantitative measurements, and differential prognosis which improves diagnostic accuracy and optimizes remedy choice.
However, there may be little analysis on the consideration of clinicians within the age of AI. Concerns have been raised as as to if medical doctors will finally get replaced by AI. From this viewpoint, the authors elaborate on the unlikelihood of AI fully changing medical doctors and discover how medical doctors can adapt their roles to help profitable integration of AI into present medical methods and procedures.
Article reference: Fengyi Zeng, Xiaowen Liang and Zhiyi Chen, New Roles for Clinicians within the Age of Artificial Intelligence. BIO Integration, 2020, https:/
BIO Integration is totally open entry journal which can enable for the fast dissemination of multidisciplinary views driving the progress of contemporary medication.
As a part of its mandate to assist deliver attention-grabbing work and information from all over the world to a wider viewers, BIOI will actively assist authors by way of open entry publishing and thru waiving writer charges in its first years. Also, publication assist for authors whose first language just isn’t English shall be provided in areas comparable to manuscript growth, English language enhancing and art work help.
BIOI is now open for submissions; articles may be submitted on-line at:
Please go to http://www.
Editorial Board: https:/
BIOI is on the market on the IngentaConnect platform (https:/
Submissions could also be made utilizing ScholarOne (https:/
There are not any writer submission or article processing charges.
Follow BIOI on Twitter @JournalBio; Facebook (https:/
Keywords: Artificial intelligence, chest imaging evaluation, COVID-19, deep studying, imaging findings
Disclaimer: AAAS and EurekAlert! usually are not chargeable for the accuracy of stories releases posted to EurekAlert! by contributing establishments or for the usage of any data by way of the EurekAlert system.